Chlamydia trachomatis evokes a relative anti-inflammatory response in a free Ca2+ dependent manner in human macrophages

Comparative Immunology, Microbiology and Infectious Diseases

Volumn 33, Issue 6, 2010, Pages 513-528

  Azenabor, Anthony A ^a   York, Jenniffer ^a  

^a UNIVERSITY OF WISCONSIN MILWAUKEE   (United States)

Author keywords

Ca2+ signaling; Chlamydia trachomatis; Macrophage anti inflammatory response; Reversal of IL 12:IL 10 ratio

Indexed keywords

CALCIUM ION; ETHYLENE GLYCOL 1,2 BIS(2 AMINOPHENYL) ETHER N,N,N',N' TETRAACETIC ACID; HEAT SHOCK PROTEIN 60; INTERLEUKIN 10; INTERLEUKIN 12; OUTER MEMBRANE PROTEIN;

ARTICLE; CALCIUM CELL LEVEL; CALCIUM SIGNALING; CALCIUM TRANSPORT; CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CULTURE MEDIUM; CYTOSOL; HOST PATHOGEN INTERACTION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; INFLAMMATION; MACROPHAGE FUNCTION; NONHUMAN; PATHOPHYSIOLOGY;

CALCIUM; CALCIUM SIGNALING; CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; EGTAZIC ACID; ENZYME-LINKED IMMUNOSORBENT ASSAY; HEAT-SHOCK PROTEINS; HUMANS; INTERLEUKIN-10; INTERLEUKIN-12; MACROPHAGES; PORINS;

CHLAMYDIA; CHLAMYDIA TRACHOMATIS;

EID: 78650222339     PISSN: 01479571     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cimid.2009.09.002     Document Type: Article

References (40)

1. Sibille Y., Reynolds H. Macrophages and polymorphonuclear neutrophils in lung defense and injury. Am Rev Respir Dis 1990, 141:471-475.
2. Laskin D.L., Pendino K.J. Macrophages and inflammatory mediators in tissue injury. Annu Rev Pharmacol Toxicol 1995, 35:655-677.
3. Duffield J.S. The inflammatory macrophage: a story of Jekyll and Hyde. Clin Sci (Colch) 2003, 104:27-38.
4. Flierl M.A., Nadeau B.A., Sarma J.V., Day D.E., Lentsch A.B., Huber-Lang M.S., et al. Upregulation of phagocyte-derived catecholamines augments the acute inflammatory response. PLoS ONE 2009, 4:e4414.
5. Redecke V., Dalhoff K., Bohnet S., Braun J., Maass M. Interaction of Chlamydia pneumoniae and human alveolar macrophages: infection and inflammatory response. Am J Respir Cell Mol Biol 1998, 19:721-727.
6. Wyrick P.B., Brownridge E.A. Growth of Chlamydia psittaci in macrophages. Infect Immun 1978, 19:1054-1060.
7. Morrison R.P., Lyng K., Caldwell H.D. Chlamydial disease pathogenesis: ocular hypersensitivity elicited by a genus-specific 57-kD protein. J Exp Med 1989, 169:663-675.
8. Witkin S.S. Immune pathogenesis of asymptomatic Chlamydia trachomatis infections in the female genital tract. Infect Dis Obstet Gynecol 1995, 3:169-174.
9. Beatty W.L., Morrison R.P., Byrne G.I. Persistent Chlamydiae: from cell culture to a paradigm for chlamydial pathogenesis. Microbiol Rev 1994, 58:686-699.
10. Jendro M.C., Deutsch T., Körber B., Köhler L., Kuipers J.G., Krausse-Opatz B., et al. Infection of human monocyte-derived macrophages with Chlamydia trachomatis induces apoptosis of T cells: a potential mechanism for persistent infection. Infect Immun 2000, 68:6704-6711.
11. Wyrick P.B. Intracellular survival by Chlamydia. Cell Microbiol 2000, 2:275-282.
12. Mpiga P., Ravaoarinoro M. Chlamydia trachomatis persistence: an update. Microbiol Res 2006, 161:9-19.
13. Burnham R.C., Peeling R.W. Chlamydia trachomatis antigens: role in immunity and pathogenesis. Infect Agents Dis 1994, 3:218-233.
14. Cohen C.R., Brunham R.C. Pathogenesis of Chlamydia induced pelvic inflammatory disease. Sex Transm Infect 1999, 75:21-24.
15. Bavoil P.M., Hsia R., Ojcius D.M. Closing in on Chlamydia and its intracellular bag of tricks. Microbiology 2000, 146:2723-2731.
16. Lundemose A.G., Birkelund S., Larson P.M., Fey S.J., Christiansen G. Characterization and identification of early proteins in Chlamydia trachomatis serovar L2 by two-dimensional gel electrophoresis. Infect Immun 1990, 58:2478-2486.
17. Stepens R.S., Wagar E.A., Edman U. Developmental regulation of tendem promoters for the major outer membrane protein gene of Chlamydia trachomatis. J Bacteriol 1988, 170:744-750.
18. 2+ channel antagonists alter Chlamydia pneumoniae MOMP and HSP-60 mRNA gene expression, and improve antibiotic susceptibility. Immunobiology 2003, 207:237-245.
19. 2+ regulates bacterial lipopolysaccharide induction of iNOS in human macrophages. Immunobiology 2009, 214:143-152.
20. Caldwell H.D., Kromjout J., Schachter J. Purification and partial characterization of the major outer membrane protein of Chlamydia trachomatis. Infect Immun 1981, 31:1161-2152.
21. 2+ in insulin-stimulated glucose transport in 3T3-L1 cells. J Biol Chem 2001, 276:27816-27824.
22. 2+ signaling events. Biol Chem 2004, 385:67-74.
23. 2+ release and directly activates ion channels in mouse pancreatic acinar cells. Biochem J 1997, 324:645-651.
24. 2+ dependent reactive nitrogen and oxygen species. J Infect 2003, 46:120-128.
25. 2+ influx and down regulates interleukin-2 receptor in mouse thymocytes. Biochem Biophys Res Commun 2001, 281:277-281.
26. Smith P.K., Krohin R.I., Hermansan G.T., Mallia A.K., Gartner F.H., Provenzano M.D., et al. Measurement of protein using bicinchoninic acid. Anal Biochem 1985, 150:76-85.
27. 2+ channel activation. Med Microbiol Immunol 2003, 192:99-106.
28. Azenabor A.A., Yang S., Job G., Adedokun O.O. Elicitation of ROS in Chlamydia pneumoniae stimulated macrophages: a Ca2+ dependent process involving simultaneous activation of NADPH-oxidase and cytochrome oxidase genes. Med Microbiol Immunol 2005, 194:91-103.
29. Fadok V.A., Bratton D.L., Konowal A., Freed P.W., Westcott J.Y., Henson P.M. Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-β, PGE2, and PAF. J Clin Invest 1998, 101:890-898.
30. Mosser D.M., Edwards J.P. Exploring the full spectrum of macrophage activation. Nat Rev Immunol 2008, 8:958-969.
31. Gordon S. The macrophages: past, present and future. Eur J Immunol 2007, 37:S9-S17.
32. Kuo C. Cultures of Chlamydia trachomatis in mouse peritoneal macrophages: factors affecting organism growth. Infect Immun 1978, 20:439-445.
33. Manor E., Sarov I. Fate of Chlamydia trachomatis in human monocytes and monocyte-derived macrophages. Infect Immun 1986, 54:90-95.
34. Gérard H.C., Köhler L., Branigan P.J., Zeidler H., Schumacher H.R., Hudson A.P. Viability and gene expression in Chlamydia trachomatis during persistent infection of cultured human monocytes. Med Micro Immun 1998, 187:115-120.
35. Aral S.O., Hughes J.P., Stoner B., Whittington W., Handsfield H.H., Anderson R.M., et al. Sexual mixing patterns in the spread of gonococcal and chlamydial infections. Am J Public Health 1999, 89:825-833.
36. Beagley K.W., Timms P. Chlamydia trachomatis infection: incidence, health costs and prospects for vaccine development. J Reprod Immunol 2000, 48:47-68.
37. Bébéar C., de Barbeyrac B. Genital Chlamydia trachomatis infections. Clin Microbiol Infect 2009, 15:4-10.
38. Morrison R.P. New insights into a persistent problem-chlamydial infections. J Clin Invest 2003, 111:1647-1649.
39. Azenabor A.A., Muili K., Akoachere J.F., Chaudhry A. Macrophage antioxidant enzymes regulate Chlamydia pneumoniae chronicity: evidence of the effect of redox balance on host-pathogen relationship. Immunobiology 2006, 211:325-339.
40. Linke A., Kuhn R., Muller W., Hanarvar N., Li C., Langhorne J. Plasmodium chabaudi chabaudi: differential susceptibility of gene-targeted mice deficient in IL-10 to an erythrocytic-stage infection. Exp Parasitol 1996, 84:253-263.